MwanzoABCL • NASDAQ
add
AbCellera Biologics Inc
$ 3.61
Baada ya Saa za Kazi:(2.50%)+0.090
$ 3.70
Imefungwa: 27 Feb, 20:00:00 GMT -5 · USD · NASDAQ · Kanusho
Bei iliyotangulia
$ 3.59
Bei za siku
$ 3.36 - $ 3.62
Bei za mwaka
$ 1.89 - $ 6.52
Thamani ya kampuni katika soko
1.09B USD
Wastani wa hisa zilizouzwa
4.47M
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 44.85M | 788.18% |
Matumizi ya uendeshaji wa biashara | 23.34M | 8,713.28% |
Mapato halisi | -8.94M | 73.85% |
Kiwango cha faida halisi | -19.94 | 97.06% |
Mapato kwa kila hisa | -0.03 | 75.00% |
EBITDA | -22.46M | 13.76% |
Asilimia ya kodi ya mapato | 54.13% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 533.83M | -14.67% |
Jumla ya mali | 1.36B | -0.26% |
Jumla ya dhima | 390.05M | 28.11% |
Jumla ya hisa | 966.90M | — |
hisa zilizosalia | 303.16M | — |
Uwiano wa bei na thamani | 1.11 | — |
Faida inayotokana na mali | -5.27% | — |
Faida inayotokana mtaji | -6.45% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -8.94M | 73.85% |
Pesa kutokana na shughuli | -34.74M | -334.29% |
Pesa kutokana na uwekezaji | 75.14M | 110.45% |
Pesa kutokana na ufadhili | 4.12M | -0.65% |
Mabadiliko halisi ya pesa taslimu | 44.80M | 50.92% |
Mtiririko huru wa pesa | -6.97M | 90.38% |
Kuhusu
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2012
Makao Makuu
Tovuti
Wafanyakazi
562
